Molecular Drug Targets for Caner Therapy

ISBN-978-0-6483304-1-7

Description
Cancer is an abnormal growth of cells caused by multiple changes in gene expression leading to dysregulated balance of cell proliferation and cell death and ultimately evolving into a population of cells that can invade tissues and metastasize to distant sites, causing significant morbidity. Basically, dysregulation or mutations of the components of the signalling molecules can promote tumorigenesis. Singling pathways include MAPK, PI3K/Akt, mTOR, Wnt/β-catenin, STAT3, FOXO, Notch, Mitophagy, Hedghog were few examples for converting the normal cell to cancer cells. On the other hand, these signalling molecules were targeted to develop drugs against the cancer. In this book, we would like to document all the signalling pathways that were dysregulated in various cancers.
Table of Contents
Title View full PDF
Preface View full PDF
Contributors View full PDF
Content View full PDF
CONTENT
1. Estrogen Receptor Signaling in Breast Cancer
Prakash Bansode
1-29
2. Exploring The Signaling Pathways That Regulate Prostate Cancer
Mohamed Suhail N and Ashok Kumar Pandurangan
30-56
3. Role of Autophagy in Anticancer Research
Barbi Gogoi and S. P. Saikia
57-74
4 Epithelial-To-Mesenchymal Transition (EMT), A Latent Conflict on Cancer
Thushara Thulaseedharan L and Hafeef Roshan K T
75-88
5 Hypoxia And Cancer Metabolism
A. Bharath kumar, Umashankar Marakanam Srinivasan, Ashok Kumar Pandurangan
89-105
6. The Pathological and Molecular Alterations in Lung Cancer
Veena Priyadharini and Ashok Kumar Pandurangan
106-123
7. The role of Galectin-3 in breast cancer and its association with metastasis
Gokul S and Ashok Kumar Pandurangan
124-133
8. Estrogen Receptor Signaling as A Target for Novel Breast Cancer Therapeutics
Mohammad Salman Akhtar, Naseem Akhter, Arshi Talat and Abrar Ahmad
134-159
9. The Potential of Hypoxia Targeted Cancer Cell Therapy and Its Molecular Mechanism
K.R.Padma and K.R. Don
160-177
10. Inflammatory Breast Cancer: Molecular Mechanism and Future Medical Insights
Haripriya Kumaravel and Ashok Kumar Pandurangan
178-193